mRNA biotherapeutics landscape for rare genetic disorders

Akinc A, Maier MA, Manoharan M, et al. 2019 The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14 1084–1087

Article  ADS  CAS  PubMed  Google Scholar 

Al Hafid N and Christodoulou J 2015 Phenylketonuria: a review of current and future treatments. Transl. Pediatr. 4 304–317

PubMed  PubMed Central  Google Scholar 

Alton EWFW AD, Ashby D, et al. on behalf of the UK Cystic Fibrosis Gene Therapy Consortium 2016 A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis (https://www.ncbi.nlm.nih.gov/books/NBK373648/)

An D, Schneller JL, Frassetto A, et al. 2017 Systemic messenger RNA therapy as a treatment for methylmalonic acidemia. Cell Rep. 21 3548–3558

Article  CAS  PubMed  PubMed Central  Google Scholar 

An D, Frassetto A, Jacquinet E, Eybye M, et al. 2019 Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia. eBioMedicine 45 519–528

Anderson BR, Muramatsu H, Nallagatla SR, et al. 2010 Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38 5884–5892

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson EJ, Creech CB, Berthaud V, et al. 2022 Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age. N. Engl. J. Med. 387 1673–1687

Article  CAS  PubMed  Google Scholar 

Antoniou P, Miccio A and Brusson M 2021 Base and prime editing technologies for blood disorders. Front. Genome Ed. 3

Asrani KH, Farelli JD, Stahley MR, et al. 2018 Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA. RNA Biol. 15 756–762

PubMed  PubMed Central  Google Scholar 

August A, Attarwala HZ, Himansu S, et al. 2021 A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat. Med. 27 2224–2233

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baden LR, El Sahly HM, Essink B, et al. 2021 Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384 403–416

Article  CAS  PubMed  Google Scholar 

Bailey AL and Cullis PR 1994 Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. Biochemistry 33 12573–12580

Article  CAS  PubMed  Google Scholar 

Baker RE and Shiman R 1979 Measurement of phenylalanine hydroxylase turnover in cultured hepatoma cells. J. Biol. Chem. 254 9633–9639

Article  CAS  PubMed  Google Scholar 

Baruteau J, Cunningham SC, Yilmaz BS, et al. 2021 Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys. Mol. Ther. Methods. Clin. Dev. 23 135–146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bavli Y, Chen B-M, Gross G, et al. 2023 Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine). J. Control. Release 354 316–322

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benenato K, Kumarasinghe ES and Cornebise M 2017 Compounds and compositions for intracellular delivery of therapeutic agents. US patent US20170210697

Bhandari JTP and Yadav D 2022 Crigler-Najjar syndrome (StatPearls Publishing) (https://www.ncbi.nlm.nih.gov/books/NBK562171/)

Bhat B, Karve S and Anderson DG 2021 mRNA therapeutics: beyond vaccine applications. Trends Mol. Med. 27 923–924

Article  CAS  PubMed  Google Scholar 

Bin Sawad A, Jackimiec J, Bechter M, et al. 2022 Epidemiology, methods of diagnosis, and clinical management of patients with arginase 1 deficiency (ARG1-D): A systematic review. Mol. Genet. Metab. 137 153–163

Article  CAS  PubMed  Google Scholar 

Blankenship CS 2008 To manage costs of hemophilia, patients need more than clotting factor. Biotechnol. Healthc. 5 37–40

PubMed  PubMed Central  Google Scholar 

Blankenship K 2019 Alnylam wins FDA nod for $575,000 liver med Givlaari despite safety flags (https://www.fiercepharma.com/pharma/alnylam-scores-fda-approval-for-rare-liver-disease-med-givlaari)

Büning H 2013 Gene therapy enters the pharma market: the short story of a long journey. EMBO Mol. Med. 5 1–3

Article  PubMed  PubMed Central  Google Scholar 

Burke T, Asghar S, O’Hara J, et al. 2021 Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys. Orphanet J. Rare Dis. 16 143

Article  PubMed  PubMed Central  Google Scholar 

Cacicedo ML, Weinl-Tenbruck C, Frank D, et al. 2022a Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice. Front. Bioeng. Biotechnol. 10 993298

Article  PubMed  PubMed Central  Google Scholar 

Cacicedo ML, Weinl-Tenbruck C, Frank D, et al. 2022b mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model. Mol. Ther. Methods. Clin. Dev. 26 294–308

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao J, An D, Galduroz M, et al. 2019 mRNA therapy improves metabolic and behavioral abnormalities in a murine model of citrin deficiency. Mol. Ther. 27 1242–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao J, Novoa EM, Zhang Z, et al. 2021a High-throughput 5′ UTR engineering for enhanced protein production in non-viral gene therapies. Nat. Commun. 12 4138

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Cao J, Choi M, Guadagnin E, et al. 2021b mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease. Nat. Commun. 12 3090

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Chander N, Basha G, Yan Cheng MH, et al. 2023 Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues. Mol. Ther. Methods Clin. Dev. 30 235–245

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chavin SI 1984 Factor VIII: structure and function in blood clotting. Am. J. Hematol. 16 297–306

Article  CAS  PubMed  Google Scholar 

Chen C-Y, Tran DM, Cavedon A, et al. 2020 Treatment of hemophilia A using factor VIII messenger RNA lipid nanoparticles. Mol. Ther. Nucleic Acids 20 534–544

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, Wang SK, Belk JA, et al. 2023a Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41 262–272

Article  CAS  PubMed  Google Scholar 

Chen T, Gao Y, Zhang S, et al. 2023b Methylmalonic acidemia: Neurodevelopment and neuroimaging. Front. Neurosci. 17 1110942

Article  PubMed  PubMed Central  Google Scholar 

Cheng Q, Wei T, Jia Y, et al. 2018 Dendrimer-based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I. Adv. Mater. 30 e1805308

Article  PubMed  Google Scholar 

Cheng Q, Wei T, Farbiak L, et al. 2020 Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 15 313–320

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Chou JY and Mansfield BC 2008 Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease. Hum. Mutat. 29 921–930

Article  CAS  PubMed  PubMed Central  Google Scholar 

Connolly B, Isaacs C, Cheng L, et al. 2018 SERPINA1 mRNA as a treatment for Alpha-1 antitrypsin deficiency. J. Nucleic Acids 2018 8247935

Article  PubMed  PubMed Central  Google Scholar 

Corbett KS, Edwards DK, Leist SR, et al. 2020 SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586 567–571

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Cui T, Li B and Li W 2022 NTLA-2001: opening a new era for gene therapy. Life Med. 1 49–51

Article  Google Scholar 

Da Silva Sanchez A, Paunovska K, Cristian A, et al. 2020 Treating cystic fibrosis with mRNA and CRISPR. Hum. Gene. Ther. 31 940–955

Article  PubMed  PubMed Central  Google Scholar 

Dass CR 2004 Lipoplex-mediated delivery of nucleic acids: factors affecting in

Comments (0)

No login
gif